Clinical

A unique St. Jude initiative is accelerating clinical CAR–T cell research in a lab-to-clinic-to-lab loop.

A new St. Jude study uncovers genetic factors behind pediatric thyroid cancer risk.

St. Jude clinicians collaborate with fellow palliative care experts to advocate for bringing palliative care to patients with sickle cell disease.

Two St. Jude efforts independently uncovered the predisposition gene’s role.

Neurosurgeon Paul Klimo, MD, explains posterior fossa syndrome, and how surgeons can work to reduce its risk.

Find about these free resources, which scientists keep current with the most current survivorship research.

In a first-in-human trial, investigators at St. Jude are using the power of PET paired with novel radiotracer, [18F]fluoromannitol, to diagnose bacterial infections in patients.

See the long-term impact a hemophilia B gene therapy trial had on one of its participants

3D printing of pharmaceuticals is making it easier for pediatric patients to take their medicine.

Expanding access to cochlear implants could have large benefits for survivors.